Covid-19: Pharma companies to play important role in India

The Indian pharmaceutical companies are well-known for producing affordable low-cost medicines and in upcoming time these companies will play an important role in the global fight against the novel coronavirus pandemic that has affected over 2.5 million people across the world, India’s top diplomat here has said.

Taranjit Singh Sandhu, India’s diplomat said that India and the US are prepared to face this pandemic situation. India is one of the largest producers of anti-malarial drug hydroxychloroquine. India has sent the drug to over 50 countries over the last few days, including the United States, he further added.

“Indian pharmaceutical companies are global leaders in producing affordable low-cost medicines and will play an important role in the fight against this pandemic,” Sandhu said in his video conferencing with Asia Society Policy Institute Senior Fellow Puneet Talwar.

“Perhaps the most successful tangible example of our successful bilateral cooperation in recent years was the development of the rotavirus vaccine, which saves thousands of lives every year,” he said.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework